Lisinopril And Hydrochlorothiazide
Product Images NDC 10544-564

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 10544-564). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (10544 564 30 68180 519 02)

Packaging label for Lisinopril and Hydrochlorothiazide Tablets USP 20 mg / 12.5 mg by Blenheim Pharmacal, Inc. The label shows a 30-tablet bottle with the NDC 10544-564-30, prescription-only status, storage instructions, and manufacturing lot information.*

FDA Label Image

Lisinopril Structural Formula (515f735c 5dba 43d9 8a58 97a319cafd56 01)

Chemical structure of the active ingredient in LISINOPRIL AND HYDROCHLOROTHIAZIDE, showing the molecular arrangement including functional groups and two water molecules (dihydrate form).*

FDA Label Image

Hydrochlorothiazide Structural Formula (515f735c 5dba 43d9 8a58 97a319cafd56 02)

Chemical structure of the active ingredient depicted in the image, showing a chlorinated benzene ring with sulfonamide and amine groups attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.